Neumora Therapeutics, Inc. Common Stock (NMRA) Insider Trading
- $61,619,186.74
- $1,390,512.62
- Oct. 18, 2024
- Kristina Burow
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 18, 2024 | Director | 14,049 | $17.03 | Sell | $239,254.47 | |
Oct. 9, 2024 | Insider | 5,563 | $15.01 | Sell | $83,500.63 | |
Sept. 17, 2024 | Insider | 30,788 | $11.81 | Sell | $363,606.28 | |
Aug. 26, 2024 | CFO | 31,642 | $11.78 | Sell | $372,742.76 | |
Aug. 22, 2024 | CFO | 28,496 | $11.63 | Sell | $331,408.48 | |
Nov. 14, 2023 | Major Shareholder | 3,357 | $11.98 | Buy | $40,216.86 | |
Nov. 13, 2023 | Director | 31,653 | $11.75 | Buy | $371,922.75 | |
Nov. 10, 2023 | Director | 17,275 | $11.49 | Buy | $198,489.75 | |
Nov. 9, 2023 | Major Shareholder | 31,079 | $10.53 | Buy | $327,261.87 | |
Nov. 8, 2023 | Director | 92,251 | $11.03 | Buy | $1,017,528.53 | |
Nov. 7, 2023 | Major Shareholder | 30,192 | $11.50 | Buy | $347,208.00 | |
Nov. 6, 2023 | Director | 43,082 | $11.55 | Buy | $497,597.10 | |
Nov. 3, 2023 | Director | 22,420 | $11.38 | Buy | $255,139.60 | |
Sept. 29, 2023 | Major Shareholder | 34,560 | $13.98 | Buy | $483,148.80 | |
Sept. 28, 2023 | Director | 41,951 | $13.44 | Buy | $563,821.44 | |
Sept. 27, 2023 | Major Shareholder | 24,504 | $12.31 | Buy | $301,644.24 | |
Sept. 26, 2023 | Director | 34,000 | $11.73 | Buy | $398,820.00 | |
Sept. 25, 2023 | Major Shareholder | 60,740 | $11.22 | Buy | $681,502.80 | |
Sept. 22, 2023 | Major Shareholder | 40,000 | $11.14 | Buy | $445,600.00 | |
Sept. 19, 2023 | CEO | 15,000 | $12.62 | Buy | $189,300.00 | |
Sept. 19, 2023 | Director | 1,500,000 | $17.00 | Buy | $25,500,000.00 | |
Sept. 19, 2023 | Major Shareholder | 1,764,705 | $17.00 | Buy | $29,999,985.00 |
Insiders are both buying and selling Neumora Therapeutics, Inc. Common Stock stock.
The insider traders at Neumora Therapeutics, Inc. Common Stock are: Kristina Burow, Arch Venture Partners Xii, Llc, Joshua Pinto, Robert A Lenz, Henry O Gosebruch, Matthew K Fust, and Amgen Inc
The most active insider trader at Neumora Therapeutics, Inc. Common Stock is Kristina Burow with 8 trades.
Joshua Pinto has sold the most Neumora Therapeutics, Inc. Common Stock stock with a total value of $1,076,894.00.
Amgen Inc has bought the most Neumora Therapeutics, Inc. Common Stock stock with a total value of $59,999,970.00.
The most recent insider trade for Neumora Therapeutics, Inc. Common Stock was on Oct. 18, 2024.
The single biggest insider buy for Neumora Therapeutics, Inc. Common Stock was from Amgen Inc with a total value of $29,999,985.00 on Sept. 19, 2023.
The single biggest insider sell for Neumora Therapeutics, Inc. Common Stock was from Joshua Pinto with a total value of $372,742.76 on Aug. 26, 2024.